Patents by Inventor Rhett P. Ketterling

Rhett P. Ketterling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TBL1XR1 and TP63 translocations
    Patent number: 9677137
    Abstract: This document provides methods and materials involved in detecting translocations of TBL1XR1 and TP63 nucleic acid. For example, methods and materials for detecting TBL1XR1 and TP63 gene rearrangements (e.g., translocations) associated with cancer (e.g., T-cell lymphomas) as well as methods and materials for detecting cancers (e.g., T-cell lymphomas) with a dominant negative TP63 phenotype are provided.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: June 13, 2017
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: George Vasmatzis, Andrew L. Feldman, Sarah H. Johnson, Rhett P. Ketterling, Ryan A. Knudson, Kathryn E. Pearce, Julie C. Porcher
  • TBL1XR1 AND TP63 TRANSLOCATIONS
    Publication number: 20150037796
    Abstract: This document provides methods and materials involved in detecting translocations of TBL1XR1 and TP63 nucleic acid. For example, methods and materials for detecting TBL1XR1 and TP63 gene rearrangements (e.g., translocations) associated with cancer (e.g., T-cell lymphomas) as well as methods and materials for detecting cancers (e.g., T-cell lymphomas) with a dominant negative TP63 phenotype are provided.
    Type: Application
    Filed: February 27, 2013
    Publication date: February 5, 2015
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: George Vasmatzis, Andrew L. Feldman, Sarah H. Johnson, Rhett P. Ketterling, Ryan A. Knudson, Kathryn E. Pearce, Julie C. Porcher